VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ACLSAxcelis Technologies, Inc.
$173.23$5.3B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksACLSFinancials

Axcelis Technologies, Inc. (ACLS) Financials

27Y historyFree accessUpdated daily

Revenue growth has contracted significantly, with EPS falling from $2.15 in 2023Q4 to $0.30 in 2026Q1 as operating margins compressed to 4.0%.

ACLS Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99
Sales/Revenue845.44M839.05M1.02B1.13B920M662.43M474.56M342.96M442.57M410.56M266.98M301.5M203.05M195.63M203.38M319.42M275.21M133.02M250.21M404.8M461.72M372.54M507.98M321.97M309.7M365.26M680.4M397.27M
Revenue Growth %-11.75%-17.57%-9.97%22.89%38.88%39.59%38.37%-22.51%7.8%53.78%-11.45%48.48%3.79%-3.81%-36.33%16.06%106.89%-46.84%-38.19%-12.33%23.94%-26.66%57.77%3.96%-15.21%-46.32%71.27%-
Cost of Goods Sold476.78M462.2M563.21M639.3M518.21M375.98M275.98M198.81M262.94M260.31M167.38M199.79M132.89M127.7M145.21M204.68M189.37M104.96M187.6M251.94M270.2M218.11M296.45M217.62M205.74M234.24M372.56M230.38M
COGS % of Revenue-55.09%55.33%56.55%56.33%56.76%58.15%57.97%59.41%63.4%62.69%66.27%65.45%65.27%71.4%64.08%68.81%78.9%74.98%62.24%58.52%58.55%58.36%67.59%66.43%64.13%54.76%57.99%
Gross Profit368.66M376.85M454.65M491.3M401.79M286.44M198.58M144.15M179.64M150.25M99.6M101.71M70.16M67.94M58.17M114.74M85.84M28.06M62.62M152.86M191.51M154.43M211.53M104.35M103.97M131.03M307.84M166.88M
Gross Margin %43.61%44.91%44.67%43.45%43.67%43.24%41.85%42.03%40.59%36.6%37.31%33.73%34.55%34.73%28.6%35.92%31.19%21.1%25.02%37.76%41.48%41.45%41.64%32.41%33.57%35.87%45.24%42.01%
Gross Profit Growth %--17.11%-7.46%22.28%40.27%44.24%37.76%-19.75%19.56%50.85%-2.07%44.95%3.28%16.79%-49.3%33.67%205.87%-55.18%-59.04%-20.18%24.01%-26.99%102.71%0.37%-20.65%-57.44%84.46%-
Operating Expenses270.56M257.53M243.86M225.51M189.43M159.12M140.54M119.95M119.68M102.41M82.69M80.97M78.2M81.39M92.84M107.61M99.2M91.96M153.51M171.02M167.09M163.81M-330.6M152.5M162.28M193.27M203.21M154.55M
OpEx % of Revenue-30.69%23.96%19.95%20.59%24.02%29.62%34.97%27.04%24.94%30.97%26.86%38.51%41.6%45.65%33.69%36.05%69.13%61.35%42.25%36.19%43.97%-65.08%47.36%52.4%52.91%29.87%38.9%
Selling, General & Admin160.21M148.57M138.36M128.6M111.07M93.69M78.71M66.02M67.8M59.33M48.29M48.38M44.67M46.63M52.44M60.43M59.68M59.3M87.63M91.69M92.16M90.46M93.74M87.26M88.75M107.45M116.63M83.87M
SG&A % of Revenue-17.71%13.59%11.37%12.07%14.14%16.59%19.25%15.32%14.45%18.09%16.05%22%23.84%25.79%18.92%21.69%44.58%35.02%22.65%19.96%24.28%18.45%27.1%28.66%29.42%17.14%21.11%
Research & Development110.35M108.96M105.5M96.91M78.36M65.43M61.83M53.93M51.88M43.07M34.4M32.59M33.53M34.76M40.4M47.18M39.52M32.66M63.26M72.04M72.38M70.91M63.21M63.28M72.07M76.54M68.77M51.6M
R&D % of Revenue-12.99%10.36%8.57%8.52%9.88%13.03%15.73%11.72%10.49%12.89%10.81%16.51%17.77%19.86%14.77%14.36%24.55%25.28%17.8%15.68%19.03%12.44%19.66%23.27%20.95%10.11%12.99%
Other Operating Expenses000000000396K-764K-601K0000002.62M7.28M2.55M2.45M-487.55M1.96M1.46M9.28M17.81M19.08M
Operating Income98.11M119.31M210.79M265.8M212.36M127.33M58.04M24.2M59.96M47.84M16.62M20.72M-10.66M-14.62M-30.94M7.13M-13.37M-69.43M-186.84M-20.66M23.74M-15.88M541.13M-53.05M-58.32M-62.24M104.64M12.33M
Operating Margin %11.6%14.22%20.71%23.51%23.08%19.22%12.23%7.06%13.55%11.65%6.23%6.87%-5.25%-7.47%-15.21%2.23%-4.86%-52.2%-74.67%-5.1%5.14%-4.26%106.53%-16.48%-18.83%-17.04%15.38%3.1%
Operating Income Growth %--43.4%-20.69%25.16%66.79%119.37%139.79%-59.63%25.33%187.81%-19.77%294.33%27.07%52.75%-533.79%153.36%80.75%62.84%-804.21%-187.04%249.51%-102.93%1119.97%9.03%6.31%-159.49%748.43%-
EBITDA115.85M136.93M226.6M278.86M223.97M138.14M67.98M32.09M65.73M52.84M20.88M25.59M-6.08M-9.54M-24.06M15.63M-6.32M-62M-163.27M1.25M43.88M7.85M564.12M-39.49M-46.56M-41.03M122.45M31.41M
EBITDA Margin %13.7%16.32%22.26%24.66%24.34%20.85%14.32%9.36%14.85%12.87%7.82%8.49%-2.99%-4.88%-11.83%4.89%-2.3%-46.61%-65.25%0.31%9.5%2.11%111.05%-12.27%-15.03%-11.23%18%7.91%
EBITDA Growth %-42.01%-39.57%-18.74%24.51%62.13%103.21%111.87%-51.19%24.39%153.07%-18.39%521.19%36.34%60.34%-253.95%347.22%89.8%62.03%-13182.21%-97.16%458.74%-98.61%1528.47%15.18%-13.48%-133.51%289.79%-
D&A (Non-Cash Add-back)17.74M17.61M15.81M13.07M11.61M10.82M9.94M7.88M5.77M5M4.26M4.87M4.59M5.08M6.88M8.5M7.04M7.44M23.57M21.91M20.14M23.73M22.98M13.56M11.76M21.21M17.81M19.08M
EBIT115.81M143.61M235.74M283.95M210.46M125.26M61.1M26.08M59.96M47.84M16.1M20.74M-9.1M-15.65M-32.39M7.47M-13.37M-74.93M-189.06M-18.16M24.42M-9.38M542.13M-12.13M-58.32M-62.24M104.64M12.33M
Net Interest Income15.06M16.12M18.94M12.85M-1.02M-4.63M-4.47M-2.2M-2.78M-4.41M-4.83M-4.91M-1.04M-413K45K42K96K-1.5M-5.13M000000000
Interest Income19.04M21.48M24.4M18.2M4.55M209K738K2.96M2.33M714K238K64K32K44K45K42K96K181K1.61M0000005.4M00
Interest Expense3.98M5.36M5.46M5.35M5.58M4.83M5.21M5.16M5.11M5.12M5.07M4.98M1.07M457K0001.68M6.74M000000000
Other Income/Expense17.68M18.93M19.48M12.8M-7.48M-6.9M-2.15M-3.28M-5.25M-4.01M-5.6M-5.51M494K-1.49M-1.45M339K-3.89M-7.17M-8.97M8.86M19.04M13.9M-466M-27.3M8.57M21.84M39.63M7.22M
Pretax Income115.79M138.25M230.27M278.6M204.88M120.43M55.89M20.92M54.7M43.83M11.02M15.21M-10.17M-16.1M-32.39M7.47M-17.26M-76.6M-195.8M-11.81M42.78M-1.98M75.14M-44.34M-49.74M-40.4M144.27M19.55M
Pretax Margin %13.7%16.48%22.62%24.64%22.27%18.18%11.78%6.1%12.36%10.68%4.13%5.04%-5.01%-8.23%-15.92%2.34%-6.27%-57.59%-78.25%-2.92%9.27%-0.53%14.79%-13.77%-16.06%-11.06%21.2%4.92%
Income Tax14.92M18.01M29.28M32.34M21.81M21.78M5.9M3.89M8.82M-83.13M23K527K1.1M1.04M1.65M2.39M312K865K861K-410K2.01M1.87M964K69.53M-23.59M-20.24M45.16M5.13M
Effective Tax Rate %12.88%13.03%12.72%11.61%10.64%18.08%10.56%18.58%16.12%-189.66%0.21%3.47%-10.81%-6.46%-5.08%32.04%-1.81%-1.13%-0.44%3.47%4.71%-94.5%1.28%-156.82%47.43%50.09%31.3%26.21%
Net Income100.87M120.24M200.99M246.26M183.08M98.65M49.98M17.03M45.88M126.96M11M14.68M-11.27M-17.14M-34.03M5.08M-17.57M-77.47M-196.66M-11.4M40.77M-3.85M74.17M-113.88M-26.15M-20.16M99.11M14.43M
Net Margin %11.93%14.33%19.75%21.78%19.9%14.89%10.53%4.97%10.37%30.92%4.12%4.87%-5.55%-8.76%-16.73%1.59%-6.39%-58.24%-78.6%-2.82%8.83%-1.03%14.6%-35.37%-8.44%-5.52%14.57%3.63%
Net Income Growth %-43.32%-40.18%-18.38%34.51%85.58%97.37%193.42%-62.88%-63.86%1054.07%-25.05%230.29%34.29%49.63%-770.36%128.89%77.32%60.61%-1625.43%-127.96%1157.59%-105.2%165.14%-335.47%-29.69%-120.34%586.96%-
Net Income (Continuing)100.87M120.24M200.99M246.26M183.08M98.65M49.98M17.03M45.88M126.96M11M14.68M-11.27M-17.14M-34.03M5.08M-17.57M-77.47M-196.66M-11.4M40.77M-3.85M74.17M-113.88M-26.15M-20.16M99.11M14.43M
Discontinued Operations0000000000000000000000000000
Minority Interest0000000000000000000000000000
EPS (Diluted)3.263.806.157.435.462.881.460.501.353.800.360.48-0.40-0.63-1.260.20-0.67-2.99-7.66-0.451.60-0.152.92-4.62-1.07-0.834.520.60
EPS Growth %-41.21%-38.21%-17.23%36.08%89.58%97.26%192%-62.96%-64.47%955.56%-25%220%36.51%50%-730%129.85%77.59%60.97%-1602.22%-128.13%1166.67%-105.14%163.2%-331.78%-28.92%-118.36%653.33%-
EPS (Basic)-3.816.177.525.542.941.500.521.354.110.380.52-0.40-0.64-1.280.20-0.67-2.99-7.66-0.451.60-0.153.00-4.62-1.07-0.834.520.60
Diluted Shares Outstanding30.98M31.67M32.7M33.16M33.54M34.27M34.13M33.83M34M33.44M30.95M30.23M27.86M27.22M26.9M27.27M26.13M25.9M25.68M25.47M25.34M25.08M25.3M24.63M24.48M24.3M22.02M23.66M
Basic Shares Outstanding30.72M31.57M32.55M32.76M33.04M33.55M33.26M32.56M33.99M30.87M29.2M28.59M27.86M26.79M26.59M26.56M26.13M25.9M25.68M25.47M25.26M25.08M24.88M24.63M24.48M24.3M22.02M23.66M
Dividend Payout Ratio----------------------------

Key Metrics

Growth RegimeContracting
ProfitabilityStrained
Balance SheetFortress
Cash FlowMixed
Top Statement Risk

Geopolitical export control exposure

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Cyclical Headwinds Dampen Revenue Momentum

As reported in recent financial statements, Axcelis Technologies has experienced a persistent revenue contraction, with the most recent quarterly figures showing a 3.3% growth rate that masks a broader trend of declining top-line performance compared to the peak levels observed in the 2023 fiscal year.

The transition from double-digit growth to low single-digit expansion suggests that the company is currently navigating a significant digestion period within its primary semiconductor equipment markets. Investors should monitor whether this deceleration reflects a structural shift in demand for high-energy ion implantation or merely a temporary pause in customer capital expenditure cycles.

Operating Leverage Under Significant Pressure

Based on the provided income statement data, operating margins have compressed sharply from 25.5% in 2023Q4 to just 4.0% in 2026Q1, indicating that the company's fixed-cost structure is struggling to absorb the impact of lower revenue volumes during this current industry downturn.

The erosion of operating margins suggests that the company's high-fixed-cost manufacturing and R&D base is becoming a liability during periods of revenue volatility. This trend warrants further investigation into whether management can successfully implement cost-rationalization measures to protect profitability if top-line weakness persists through the remainder of the fiscal year.

R&D Intensity Amid Revenue Contraction

According to the quarterly income statement filings, Axcelis has maintained relatively stable R&D expenditures despite the significant revenue decline, with spending hovering near $28.5M in 2026Q1, which highlights a commitment to long-term technical differentiation at the expense of near-term bottom-line performance.

Maintaining R&D intensity during a cyclical trough appears to be a strategic choice to preserve the Purion platform's competitive moat. However, this discipline creates a direct tension with net income, as the lack of expense flexibility exacerbates the impact of revenue fluctuations on the company's overall earnings quality.

Earnings Volatility Driven by Operations

Based on the reported figures, EPS has experienced a dramatic decline from $2.15 in 2023Q4 to $0.30 in 2026Q1, a trend that appears primarily driven by operational deleveraging rather than non-operating items or significant tax anomalies, suggesting a high degree of sensitivity to core business performance.

The sharp drop in EPS underscores the company's vulnerability to cyclical swings in the semiconductor equipment market. Investors should note that the consistent presence of stock-based compensation, averaging approximately $5M per quarter, continues to act as a persistent drag on net income during this period of reduced operational efficiency.

ACLS — Frequently Asked Questions

Quick answers to the most common questions about buying ACLS stock.

What was Axcelis Technologies, Inc.'s (ACLS) revenue in 2025?

For fiscal year 2025, Axcelis Technologies, Inc. (ACLS) reported total revenue of $839.0M. This represents a 111.2% increase compared to $397.3M in 1999.

Is Axcelis Technologies, Inc. (ACLS) profitable?

Axcelis Technologies, Inc. (ACLS) is profitable, generating $120.2M in net income for the fiscal year ending 2025 with a net profit margin of 14.3%.

What is Axcelis Technologies, Inc.'s operating profit margin?

Axcelis Technologies, Inc. (ACLS) reported an operating income of $119.3M, resulting in an operating profit margin of 14.2%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Axcelis Technologies, Inc.'s gross profit and gross margin?

Axcelis Technologies, Inc. (ACLS) generated $376.8M in gross profit for the year, representing a gross profit margin of 44.9%. This demonstrates the company's core pricing power and production efficiency.